Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

GERD

- PMLiVE

Early 2013 sees drug filings, launches and approvals in Japan

Includes medicines from Bayer, Takeda, Astellas and Eisai

- PMLiVE

Sexual health apps fail to attract smartphone users

HIV and STD apps not fulfilling their potential to assist with prevention and care

- PMLiVE

Takeda ends obesity alliance with Amylin

Comes more than a year after development of lead product was pulled

- PMLiVE

Actavis mounts patent challenge on Velcade in US

Plans to launch own version of Takeda’s cancer drug

- PMLiVE

Eliquis and Ryzodeg feature among Japan’s year-end approvals

Actonel and Neupro also given green light

Pharma’s 2012 … going mobile

This year patients, prescribers and the public increasingly turned to their mobile devices

- PMLiVE

Lundbeck and Takeda submit depression drug for US approval

Brintellix could help Lundbeck overcome loss of patent protection for Lexapro/Cipralex

- PMLiVE

Novo launches haemophilia tracking app

Will compete with similar apps from Pfizer, Baxter

- PMLiVE

Doctors.net.uk unveils medical quiz apps

Apps cover therapeutics, cardiology, general internal medicines and general practice

Microsoft MedicineCabinet app aims to help patients recognise adverse events

Teams up with NextGen Healthcare on mobile personal medication record application

- PMLiVE

The best mHealth apps in the world?

Global contest identifies outstanding mobile apps and services in mobile health

Mobile health gaining popularity

US study finds smartphone users lead the way

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links